China Updates the Clinical Trial Quality Management Standard for Foods for Special Medical Purpose
On May 11, 2024, China State Administration for Market Regulation (SAMR) released Clinical Trial Quality Management Standard for Fo
ods for Special Medical Purpose (hereinafter “FSMP Clinical Tr
ial Staca citratendard"), which applies to the cli
nical trial conducted for FSMP registration in China. This new regulation has jarrow formulas magnesium malatebeen effective startingtwinlab calcium citrate caps from the date of promulgation, and walgreens zinc gluconateits previous trial versabsorption of zinc glycinateion issued on October 13, 2016 has been repealed since then.